Cargando…
Impact of routine coronary catheterization in low extremity artery disease undergoing percutaneous transluminal angioplasty: study protocol for a multi-center randomized controlled trial
BACKGROUND: The prevalence of significant obstructive coronary artery disease with complex lesions is high in patients who have low extremity artery disease (LEAD). However, intermediate- or long-term cardiovascular prognosis of LEAD patients undergoing percutaneous transluminal angioplasty (PTA) re...
Autores principales: | Chen, I-Chih, Lee, Cheng-Han, Chao, Ting-Hsing, Tseng, Wei-Kung, Lin, Tsung-Hsien, Chung, Wen-Jung, Li, Jen-Kwan, Huang, Hsuan-Li, Liu, Ping-Yen, Chao, Ting-Kuang, Chu, Chuin-Yuan, Lin, Chih-Chan, Hsu, Po-Chao, Lee, Wen-Huang, Lee, Po-Tseng, Li, Yi-Heng, Tseng, Shih-Ya, Tsai, Liang-Miin, Hwang, Juey-Jen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772293/ https://www.ncbi.nlm.nih.gov/pubmed/26927298 http://dx.doi.org/10.1186/s13063-016-1237-0 |
Ejemplares similares
-
Plasma Levels of Proprotein Convertase Subtilisin/Kexin Type 9 Are Elevated in Patients With Peripheral Artery Disease and Associated With Metabolic Disorders and Dysfunction in Circulating Progenitor Cells
por: Chao, Ting‐Hsing, et al.
Publicado: (2016) -
A Randomized Controlled Trial Evaluating Outcome Impact of Cilostazol in Patients with Coronary Artery Disease or at a High Risk of Cardiovascular Disease
por: Lin, Jia-Ling, et al.
Publicado: (2022) -
Percutaneous transluminal angioplasty.
por: Curry, R., et al.
Publicado: (1982) -
Effect of cilostazol on plasma levels of proprotein convertase subtilisin/kexin type 9
por: Chen, I-Chih, et al.
Publicado: (2017) -
Comparison of 2 effect-site concentrations of remifentanil with midazolam during percutaneous transluminal balloon angioplasty under monitored anesthesia care: A randomized controlled study
por: Lai, Hou-Chuan, et al.
Publicado: (2021)